Cash on Hand for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's latest reported cash and short-term investments is $716.10M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingCash on HandSwitch metric
Latest period
$716.10M
YoY change
-24.9%
5Y CAGR
-5.4%
Peak year (2024)
$953.40M
Latest annual
$716.10M
Cash on Hand history chart for Insulet (PODD) from 2002 to 2025
Cash on Hand history table for Insulet (PODD) from 2002 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $716.10M | -24.9% | ||
| 2024 | $953.40M | +35.4% | ||
| 2023 | $704.20M | +4.4% | ||
| 2022 | $674.70M | -14.8% | ||
| 2021 | $791.60M | -16.5% | ||
| 2020 | $947.60M | +152.0% | ||
| 2019 | $376.10M | +30.2% | ||
| 2018 | $288.95M | -34.3% | ||
| 2017 | $440.06M | +47.4% | ||
| 2016 | $298.57M | +143.4% | ||
| 2015 | $122.67M | -18.9% | ||
| 2014 | $151.19M | +1.0% | ||
| 2013 | $149.73M | +161.3% | ||
| 2012 | $57.29M | -39.0% | ||
| 2011 | $93.95M | -17.1% | ||
| 2010 | $113.27M | -11.5% | ||
| 2009 | $128.00M | +125.9% | ||
| 2008 | $56.66M | -40.1% | ||
| 2007 | $94.59M | +184.6% | ||
| 2006 | $33.23M | +333.8% | ||
| 2005 | $7.66M | -68.1% | ||
| 2004 | $24.00M | +454.5% | ||
| 2003 | $4.33M | -74.5% | ||
| 2002 | $16.96M | — |
Cash on Hand values are taken from Insulet's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Insulet (PODD) cash and short-term investments totalled $716.10M – declined 24.9% year-over-year.
Through 2020–2025 (5 years), Insulet cash and short-term investments delivered a -5.4% annualised rate; with a net decline across the window.
Between 2024 and 2025, Insulet cash and short-term investments declined 24.9%, falling from $953.40M to $716.10M.
Across the available history, cash and short-term investments reached its high of $953.40M in 2024 and its low of $4.33M in 2003.
Among 8 Healthcare peers, Insulet (PODD) ranks 9th; the peer median for cash and short-term investments is $11.85B.
Insulet Cash on Hand by Year
Insulet Cash on Hand 2025: $716.10M
Insulet cash and short-term investments in 2025 was $716.10M, declined 24.9% below 2024.
Insulet Cash on Hand 2024: $953.40M
Insulet cash and short-term investments in 2024 was $953.40M, surged 35.4% from 2023. This figure represents the highest annual value in the available history.
Insulet Cash on Hand 2023: $704.20M
Insulet cash and short-term investments in 2023 was $704.20M, edged up 4.4% from 2022.
Insulet Cash on Hand 2022: $674.70M
Insulet cash and short-term investments in 2022 was $674.70M, declined 14.8% below 2021.
Insulet Cash on Hand 2021: $791.60M
Insulet cash and short-term investments in 2021 was $791.60M.
See more financial history for Insulet (PODD).
Sector peers — Cash on Hand
Companies in the same sector as Insulet, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Insulet's cash and short-term investments?
- Latest reported cash and short-term investments for Insulet (PODD) is $716.10M (period ending December 31, 2025).
How has Insulet cash and short-term investments changed year-over-year?
- Insulet (PODD) cash and short-term investments changed -24.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet cash and short-term investments?
- Insulet (PODD) cash and short-term investments compound annual growth rate is -5.4% over the most recent 5 years available.
When did Insulet cash and short-term investments hit its highest annual value?
- Insulet cash and short-term investments reached its highest annual value of $953.40M in 2024.
What was Insulet cash and short-term investments in 2024?
- Insulet (PODD) cash and short-term investments in 2024 was $953.40M.
What was Insulet cash and short-term investments in 2025?
- Insulet (PODD) cash and short-term investments in 2025 was $716.10M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.